Feed aggregator

Investors Jump In After Canada Changes Marijuana Rules

WSJ.com What's News US - 4 hours 26 min ago
In Canada, it is now legal for any licensed company to grow and ship medical marijuana to patients—and illegal for patients to grow their own. The industry is drawing investments from hedge funds and private-equity firms in the U.S. and Canada.

Breaking Down Arcam AB's Q1 Earnings -- FastEBM and New Orders

Here's what 3-D printing investors need to know about Arcam's first-quarter 2014 results.






Ex-Bank Examiner Wants Details on Judge's Husband's Work

WSJ.com What's News US - 4 hours 51 min ago
Carmen Segarra, whose lawsuit against the New York Fed alleges she was fired for her views on Goldman Sachs, asked for information on the judge's husband's work with the firm.

Ulta Slumps, Netflix Rallies on Expansion Hopes

Dow breaks three-day win streak; Disney stock advances in shortened week of trading






Even With A Change At The Top, Danaher Corporation Will Roll On

A change in the CEO, sluggish near-term trends, and a more competitive M&A market isn't likely to lead to big changes.






Earnings Roundup: Did Obamacare Swamp United Healthcare's Quarter?

Medicaid membership surged at United Healthcare (UNH) in Q1, offsetting headwinds tied to Obamacare fees and higher taxes, and suggesting strong results for Medicaid insurers Molina (MOH) and Centene (CNC).






Is Herbalife a Bad News Buy?

The hits keep on coming for this struggling stock. What should investors do?






Earnings Roundup: St. Jude's 1 Bright Spot

St Jude's (STJ) electrophysiology business is the one bright spot in an otherwise dim earnings report.






How Are Orphan Drugmakers Faring in the Great Biotech Downturn?

Orphan drugmakers led the biotech rally upward. Is it now leading it downward?






Earnings Roundup: Johnson & Johnson Results Are Better Than They Appear

Slow growth from medical device and consumer goods masked robust sales in Johnson & Johnson's drug business.






3 Reasons Rite Aid Continues to Crush the Market

Shares in Rite Aid (RAD) may keep heading higher thanks to these three reasons.






3 Key Takeaways From General Electric Company's Earnings Report

Here's what you need to know about GE's year thus far.






Big Labels Take Aim At Pandora On Royalties

NYT > Business - 5 hours 17 min ago
The suit, filed by several big record companies on Thursday, accuses Pandora of violating common-law copyright protections for songs made before 1972.






Domino's New Pizza Chicken Is Actually Great for the Company

Specialty Chicken -- a bunch of fried boneless chicken with pizza toppings -- is a nonsensical menu item that will serve the company well. This is pure marketing bliss.






Investor Beat -- More Financial Earnings

A whole slew of earnings news, including Goldman Sachs, Morgan Stanley and IBM. Plus, how Wal-Mart is taking the fight to MoneyGram and Western Union, and why this analyst is interested in Citigroup today.






Are These Aerospace and Defense Stocks Cleared for Liftoff?

The SPDR S&P Aerospace & Defense ETF offers an easy, low-cost way to buy into these enforcement-friendly aerospace and defense stocks.






Why Citigroup Is a Stock to Watch Today

Citigroup has seen some rocky roads recently. Here's why this analyst is bullish long-term.






Wal-Mart Takes the Fight to MoneyGram and Western Union

Wal-Mart takes a big step onto MoneyGram's and Western Union's turf.






Altria Learns to Avoid Coca-Cola, PepsiCo Mistakes

Altria is hell-bent on not repeating the mistakes now plaguing soda giants Coca-Cola and PepsiCo. Here's why Altria is in good shape no matter what happens.






IBM Sees Yet Another Quarter of Falling Revenue

Another quarter of falling revenue for IBM, the eighth in a row for Big Blue.






Pages

Subscribe to Oxygen Financial aggregator